MedDataX Logo

Serum Procalcitonin Level May Predict Acute Kidney Injury in ICU Patients With Sepsis

NCT ID: NCT03097393

Last Updated: 2017-03-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

67 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-01

Study Completion Date

2017-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to examine if procalcitonin (PCT) can be used for early prediction of AKI septic patients in ICU.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

67 patients with sepsis were enrolled in this study. On admission, PCT was measured together with serum creatinine, urea, and other inflammatory markers. Quick Sepsis-related Organ Failure Assessment was calculated at the emergency department. Patients were classified into those with Acute kidney injury (AKI) and non-AKI groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Kidney Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AKI GROUP

measure Procalcitonin among Patient developed Acute kidney injury during ICU stay

measure Serum procalcitonin level

Intervention Type DIAGNOSTIC_TEST

measuring procalcitonin level

Non-AKI group

measure Procalcitonin among Patient did not develop Acute kidney injury during ICU stay

measure Serum procalcitonin level

Intervention Type DIAGNOSTIC_TEST

measuring procalcitonin level

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

measure Serum procalcitonin level

measuring procalcitonin level

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ICU patients with sepsis

Exclusion Criteria

* Patient known to have End-stage kidney disease
* Patients on Renal replacement therapy
* patients without procalcitonin level within 24 hours from admission.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Benha University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mahmoud Hamada imam

Lecturer in Internal Medidicne Department- Faculty of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Benha317

Identifier Type: -

Identifier Source: org_study_id